Concepedia
8
Publications
363
Citations
H-Index
1999
Active since
Affiliations
Novo Nordisk (Denmark)(Current)
Lund University
Jacob Råstam is an author at Novo Nordisk (Denmark) specializing in measurement, pharmacotherapy, and diabetes.
Top concepts
DiabetesMedicineMeasurementPharmacologyPharmacotherapyCombination Therapy
Publications per year
1999–2013
Immune Responses to Insulin Aspart and Biphasic Insulin Aspart in People With Type 1 and Type 2 Diabetes
Anders Lindholm, Lisbeth Bjerring Jensen, Philip Home et al. · Diabetes Care · 2002 · 108 citations · Full text
Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA<sub>1c</sub>and spikes of high glucose values in the third trimester
Peter Damm, Henriette Mersebach, Jacob Råstam et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 2013 · 65 citations · Full text
Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial
Priscilla Hollander, Katarı́na Rašlová, Trine Vang Skjøth et al. · Diabetes Obesity and Metabolism · 2010 · 60 citations
Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal?bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes
Thomas Danne, Jacob Råstam, R Odendahl et al. · Pediatric Diabetes · 2007 · 41 citations
Improved glycaemic control of thrice‐daily biphasic insulin aspart compared with twice‐daily biphasic human insulin; a randomized, open‐label trial in patients with type 1 or type 2 diabetes
M. R. Clements, Jos Tits, Brendan Kinsley et al. · Diabetes Obesity and Metabolism · 2007 · 38 citations
Rows per page
1–5 of 8